Literature DB >> 11253274

[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].

S Blair1, L L Lacharme, J C Fonseca, A Tobón.   

Abstract

In 1998 we determined in vivo and in vitro the frequency and the degree of resistance of Plasmodium falciparum to the three antimalarials (chloroquine, amodiaquine, and sulfadoxine/pyrimethamine) most utilized in the municipality of Turbo (in the area of Urabá, Antioquia, Colombia), in a sample representative of the population with malaria. We carried out clinical and parasitological analyses over a 14-day period using the standard test recommended by the World Health Organization. In vivo, P. falciparum showed resistance to chloroquine, amodiaquine, and sulfadoxine/pyrimethamine, with a frequency of 97%, 7%, and 13%, respectively. In vitro, the corresponding figures were 21%, 23%, and 9%, respectively. For chloroquine the level of agreement between the in vivo and in vitro results was 23%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11253274     DOI: 10.1590/s1020-49892001000100006

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  3 in total

1.  Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.

Authors:  Vladimir Corredor; Claribel Murillo; Diego F Echeverry; Julie Benavides; Richard J Pearce; Cally Roper; Angela P Guerra; Lyda Osorio
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

2.  Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia.

Authors:  Silvia Blair; Jaime Carmona-Fonseca; Juan G Piñeros; Alexandra Ríos; Tania Alvarez; Gonzalo Alvarez; Alberto Tobón
Journal:  Malar J       Date:  2006-02-20       Impact factor: 2.979

3.  Anti-plasmodial effect of plant extracts from Picrolemma huberi and Picramnia latifolia.

Authors:  Wendy Berthi; Alexa González; Alexandra Rios; Silvia Blair; Álvaro Cogollo; Adriana Pabón
Journal:  Malar J       Date:  2018-04-04       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.